☰

Stacey A. Sakowski, Ph.D. - Publications

Affiliations: 
Wayne State University, Detroit, MI, United States 
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Goutman SA, Savelieff MG, Sakowski SA, Feldman EL. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opinion On Investigational Drugs. 1-19. PMID 31189354 DOI: 10.1080/13543784.2019.1627324  0.362
2019 Chen KS, McGinley LM, Kashlan ON, Hayes JM, Bruno ES, Chang JS, Mendelson FE, Tabbey MA, Johe K, Sakowski SA, Feldman EL. Targeted intraspinal injections to assess therapies in rodent models of neurological disorders. Nature Protocols. PMID 30610242 DOI: 10.1038/S41596-018-0095-5  0.303
2016 McGinley LM, Sims E, Lunn JS, Kashlan ON, Chen KS, Bruno ES, Pacut CM, Hazel T, Johe K, Sakowski SA, Feldman EL. Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease. Stem Cells Translational Medicine. PMID 26744412 DOI: 10.5966/Sctm.2015-0103  0.331
2015 Figueroa-Romero C, Hur J, Simon Lunn J, Paez-Colasante X, Bender DE, Yung R, Sakowski SA, Feldman EL. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Molecular and Cellular Neurosciences. PMID 26704906 DOI: 10.1016/J.Mcn.2015.12.008  0.319
2015 Chen KS, Sakowski SA, Feldman EL. Intraspinal Stem Cell Transplantation for Amyotrophic Lateral Sclerosis. Annals of Neurology. PMID 26696091 DOI: 10.1002/Ana.24584  0.397
2015 Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nature Reviews. Neurology. 11: 266-79. PMID 25896087 DOI: 10.1038/Nrneurol.2015.57  0.33
2015 Sakowski SA, Feldman EL. The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 287-9. PMID 25794940 DOI: 10.1007/S13311-015-0349-7  0.377
2015 Lunn JS, Sakowski SA, McGinley LM, Pacut C, Hazel TG, Johe K, Feldman EL. Autocrine production of IGF-I increases stem cell-mediated neuroprotection. Stem Cells (Dayton, Ohio). 33: 1480-9. PMID 25532472 DOI: 10.1002/Stem.1933  0.35
2014 Lunn JS, Sakowski SA, Feldman EL. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cells (Dayton, Ohio). 32: 1099-109. PMID 24448926 DOI: 10.1002/Stem.1628  0.374
2012 Sakowski SA, Lunn JS, Busta AS, Oh SS, Zamora-Berridi G, Palmer M, Rosenberg AA, Philip SG, Dowling JJ, Feldman EL. Neuromuscular effects of G93A-SOD1 expression in zebrafish. Molecular Neurodegeneration. 7: 44. PMID 22938571 DOI: 10.1186/1750-1326-7-44  0.38
2012 Oh SS, Sullivan KA, Wilkinson JE, Backus C, Hayes JM, Sakowski SA, Feldman EL. Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems. Neuroscience. 212: 201-13. PMID 22516022 DOI: 10.1016/J.Neuroscience.2012.03.026  0.302
2012 Sakowski SA, Lunn JS, Busta AS, Palmer M, Dowling JJ, Feldman EL. A novel approach to study motor neurons from zebrafish embryos and larvae in culture. Journal of Neuroscience Methods. 205: 277-82. PMID 22285259 DOI: 10.1016/J.Jneumeth.2012.01.007  0.318
2011 Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL. Translational stem cell therapy for amyotrophic lateral sclerosis. Nature Reviews. Neurology. 8: 172-6. PMID 22158518 DOI: 10.1038/Nrneurol.2011.191  0.345
2011 Lunn JS, Sakowski SA, Hur J, Feldman EL. Stem cell technology for neurodegenerative diseases. Annals of Neurology. 70: 353-61. PMID 21905078 DOI: 10.1002/Ana.22487  0.308
2011 Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. Stem cell technology for the study and treatment of motor neuron diseases. Regenerative Medicine. 6: 201-13. PMID 21391854 DOI: 10.2217/Rme.11.6  0.362
2011 Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. Erratum: Stem cell technology for the study and treatment of motor neuron diseases, which appeared in the February issue of Regenerative Medicine (Regen. Med. (2011) 6:2 (201-213)) Regenerative Medicine. 6. DOI: 10.2217/Rme.11.30  0.355
2009 Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Developmental Neurobiology. 69: 871-84. PMID 19672955 DOI: 10.1002/Dneu.20747  0.334
2009 Sakowski SA, Schuyler AD, Feldman EL. Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 63-73. PMID 18608100 DOI: 10.1080/17482960802160370  0.309
2008 Vincent AM, Sakowski SA, Schuyler A, Feldman EL. Strategic approaches to developing drug treatments for ALS. Drug Discovery Today. 13: 67-72. PMID 18190866 DOI: 10.1016/J.Drudis.2007.10.011  0.344
2007 Kuhn DM, Sakowski SA, Geddes TJ, Wilkerson C, Haycock JW. Phosphorylation and activation of tryptophan hydroxylase 2: identification of serine-19 as the substrate site for calcium, calmodulin-dependent protein kinase II. Journal of Neurochemistry. 103: 1567-73. PMID 17727633 DOI: 10.1111/J.1471-4159.2007.04855.X  0.493
2006 Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Research. 1085: 11-8. PMID 16581041 DOI: 10.1016/J.Brainres.2006.02.047  0.503
2006 Sakowski SA, Geddes TJ, Kuhn DM. Mouse tryptophan hydroxylase isoform 2 and the role of proline 447 in enzyme function. Journal of Neurochemistry. 96: 758-65. PMID 16405505 DOI: 10.1111/J.1471-4159.2005.03604.X  0.507
2004 Kuhn DM, Sakowski SA, Sadidi M, Geddes TJ. Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity: the beginning or the end of the end of dopamine neurons? Journal of Neurochemistry. 89: 529-36. PMID 15086510 DOI: 10.1111/J.1471-4159.2004.02346.X  0.568
Show low-probability matches.